Editorial Board for section 'Vaccination Against Cancer and Chronic Diseases'
- COVID-19 Vaccines and Vaccination Section
- Epidemiology and Vaccination Section
- Hepatitis Virus Vaccines Section
- HIV Vaccines Section
- Human Papillomavirus Vaccines Section
- Influenza Virus Vaccines Section
- Nucleic Acid (DNA and mRNA) Vaccines Section
- Pathogens-Host Immune Boundaries Section
- Vaccination Against Cancer and Chronic Diseases Section
- Vaccine Advancement, Efficacy and Safety Section
- Vaccine Design, Development, and Delivery Section
- Vaccines Against Tropical and Other Infectious Diseases Section
- Vaccines and Public Health Section
- Vaccines, Clinical Advancement, and Associated Immunology Section
- Veterinary Vaccines Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
2. Department for BioMedical Research, University of Bern, 3012 Bern, Switzerland
3. Nuffield Department of Medicine, The Jenner Institute, The Henry Wellcome Building for Molecular Physiology, University of Oxford, Oxford OX1 2JD, UK
Interests: therapeutic vaccines; non-communicable diseases; cancer; virus-like particles; antibody therapies; immunology; memory
* Section: Vaccination Against Cancer and Chronic Diseases
Special Issues, Collections and Topics in MDPI journals
Interests: colorectal cancer; sarcoma; osteosarcoma; immune response; exosomes; extra cellular vesicles; tumor immunology; microRNAs; gene regulation
* Section: Vaccination Against Cancer and Chronic Diseases
Special Issues, Collections and Topics in MDPI journals
Interests: cancer epidemiology; cancer prevention; women’s health; sexually transmitted infections; infectious diseases; prediction and mixed effects modellings; socioeconomic determinants of health
Special Issues, Collections and Topics in MDPI journals
Interests: adenovirus-vectored vaccine; gene-based vaccines; gene therapy; oncolytic viruses; virology; immunology
Special Issues, Collections and Topics in MDPI journals
Interests: cancer vaccines; immune resistance; biomarkers; immune checkpoints; immunotherapy; targeted therapy; microenvironment
Special Issues, Collections and Topics in MDPI journals
2. Department of Medicine, University of Melbourne, Melbourne, VIC 3050, Australia
3. Department of Microbiology, Monash University, Melbourne, VIC 3800, Australia
Interests: malaria vaccines; antibodies; childhood vaccines; neutrophils; monocytes; complement; implementation
Interests: antigen specific B cell responses; antibody responses
Special Issues, Collections and Topics in MDPI journals
Interests: dendritic cells; Th1; cancer immunotherapy; breast cancer
Interests: extremophiles; haloarchaea; microbial genomics; purple membrane; gas vesicle nanoparticles; vaccines and therapeutics
Special Issues, Collections and Topics in MDPI journals
Interests: cervical cancer; preinvasive lesion; ovarian cancer; endometrial cancer
2. Biomedical Research Center, School of Science, Engineering and Environment, University of Salford, Manchester, UK
3. College of Health Sciences, Abu Dhabi University, Abu Dhabi, United Arab Emirates
Interests: immunology; cancer immunotherapy; tumor immunology; T regulatory cells
Special Issues, Collections and Topics in MDPI journals
Interests: development of antiviral small molecules and antibodies
Special Issues, Collections and Topics in MDPI journals
Interests: tumor immunology; immunotherapy; animal tumor models; tumor microenvironment; innate immune agonists; antibodies and antibody fusion proteins; chemokines/cytokines/co-stimulatory molecules
Section Board Member
Interests: adjuvant therapy; melanoma; immunotherapy
Special Issues, Collections and Topics in MDPI journals
2. Department of Medicine, University of Oklahoma Health Sciences Center, Andrews Academic Tower, 800 Stanton L. Young Blvd, Oklahoma City, OK 73104, USA
Interests: immunotherapy; CAR-T cells; tumor microenvironment; checkpoint protein; hypoxia; tumor survival signaling
Special Issues, Collections and Topics in MDPI journals
Interests: antitumor immunotherapy; cell therapy; NK cell; monoclonal antibodies; antibody-dependent cell cytotoxicity; MAPK; metabolism; dichloroacetate
Interests: biology; biotechnology; vaccinology; immunology; cancer; cancer vaccines; vaccine development; microbiology; pathogens; virulence; functional analysis of virulence factors
Interests: prostate cancer; immunology; microenvironment; immunotherapy; histology; complexity; modeling
Special Issues, Collections and Topics in MDPI journals
Interests: radiation therapy; ultrasound; immune-oncology; normal tissue injury and stem cells
Interests: T-cell immunity; MHC-bound peptides; tumor and infectious disease antigens; MHC bound peptide prediction by AI; antigen processing
Interests: DNA vaccines; gene electrotransfer; tumor immunology; drug delivery; device and protocol development; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Interests: cancer vaccine; cancer stem cell; tumor-associated antigen; cancer immunotherapy
Interests: anticancer vaccines; tumor microenvironment; tumor-induced immune suppression
Interests: cytokines; innate immune receptors; autoimmune diseases; animal disease models
Interests: fish vaccine; fish lymphocyte; aquaculture; variable lymphocyte receptors of hagfish
2. Ludwig Institute for Cancer Research, Lausanne Branch, CH-1005 Lausanne, Switzerland
Interests: cancer vaccines; cellular therapies; immunotherapy; gynaecological cancers
Interests: peptide and protein design; antigenic and immunogenic determinants; peptide & protein folding
Interests: immunology; cancer immunotherapy; dendritic cell biology
2. Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden (TUD), 01069 Dresden, Germany
Interests: molecular and cellular immunology/immune regulation
Interests: herpesviruses; herpes simplex virus; glycoproteins; receptors; neutralizing antibodies; cell adhesion








